MAPT and Alzheimer disease: In the last years, however, this hypothesis was challenged: a potential role of an impairment of metabolism of amyloid precursor protein (APP) and its progress through tau pathology were considered in the etiology of AD (for review, see Kametani and Hasegawa, 2018).